The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

Dubai gears up for final phase of single-use plastic ban
UAE hails Yemen prisoner swap agreement as key humanitarian step
Sharjah receives Guinness for largest A2A2 cattle farm
UAE reinforces global humanitarian leadership
UAE offers condolences to Libya after death of army chief in plane crash
Dubai Police warn against fake ticket scams
Egyptian scientist wins UAE's 'Great Arab Minds' award in medicine
UAE contributes $2 million to support healthcare in Sudan
